Eutigoside C inhibits the production of inflammatory mediators (NO, PGE2, IL-6) by down-regulating NF-κB and MAP kinase activity in LPS-stimulated RAW 264.7 cells

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 7, 2008, Pages 917-924

  Lee, Hye Ja ^a   Oh, Tae Heon ^b   Yoon, Weon Jong ^a   Kang, Gyeoung Jin ^a   Yang, Eun Jin ^a   Park, Sun Soon ^a   Lee, Nam Ho ^b   Kang, Hee Kyoung ^a   Yoo, Eun Sook ^a  

^a Jeju National University School of Medicine   (South Korea)

^b Jeju National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; EUTIGOSIDE C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PLANT EXTRACT; PROSTAGLANDIN E2; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE; CELL NUCLEUS; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; ENZYME PHOSPHORYLATION; EURYA EMARGINATA; INFLAMMATION; MACROPHAGE; MEDICINAL PLANT; MOUSE; NONHUMAN; PLANT LEAF; PROTEIN DNA BINDING; PROTEIN TRANSPORT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; DINOPROSTONE; DOWN-REGULATION; GLUCOSIDES; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE; PHENOLS; PHOSPHORYLATION;

EID: 46249092283     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.7.0014     Document Type: Article

References (51)

1. Anderson, G. D., Hauser, S. D., McGarity, K. L., Bremer, M. E., Isakson, P. C., Gregory, S. A. (1996) Selective inhibition of cyclooxygenase (C0X)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J. Clin. Invest. 97: 2672-2679
2. Baeuerle, P. A., Baltimore, D. (1996) NF-kappa B: ten years after. Cell 87:13-20
3. Baldwin, AS Jr. (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14: 649-683
4. Bove, P. F., van der Vliet, A. (2006) Nitric oxide and reactive nitrogen species in airway epithelial signaling and inflammation. Free Radic. Biol. Med. 41: 515-527
5. Bradford, M. M. (1976) A rapid and sensitive method for the quanti-tation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254
6. 2 production. J. Biomed. Sci. 6: 425-432
7. Cho, J. Y., Baik, K. U., Jung, J. H., Park, M. H. (2000) In vitro anti-inflammatory effects of cynaropicrin, a sesquiterpene lactone, from Saussurea lappa. Eur. J. Pharmacol. 398: 399-407
8. Chung, M. G., Epperson, B. K. (2000) Clonal and spatial genetic structure in Eurya emarginata (Theaceae). Heredity 84:170-177
9. Cobb, M. H. (1999) MAP kinase pathways. Prog. Biophys. Mol. Biol. 71: 479-500
10. Fernandez, M., Rios, J. C., Jos, A., Repetto, G. (2006) Comparative cytotoxicity of alachlor on RTG-2 trout and SH-SY5Y human cells. Arch. Environ. Contam. Toxicol. 51: 515-520
11. Fujihara, M., Muroi, M., Tanamoto, K., Suzuki, T., Azuma, H., Ikeda, H. (2003) Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol. Ther. 100:171-194
12. Guha, M., Mackman, N. (2001) LPS induction of gene expression in human monocytes. Cell Signal. 13: 85-94
13. Harris, R. C., Breyer, M. D. (2006) Update on cyclooxygenase-2 inhibitors. Clin. J. Am. Soc. Nephrol. 1: 236-245
14. Harris, S. G., Padilla, J., Koumas, L., Ray, D., Phipps, R. P. (2002) Prostaglandins as modulators of immunity. Trends Immunol. 23: 144-150
15. Hinson, R. M., Williams, J. A., Shacter, E. (1996) Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2. Proc. Natl Acad. Sci. USA 93: 4885-4890
16. Inoue, J., Gohda, J., Akiyama, T., Semba, K. (2007) NF-κB activation in development and progression of cancer. Cancer Sci. 98: 268-274
17. Islam, S., Hassan, F., Mu, M. M., Ito, H., Koide, N., Mori, I., Yoshida, T., Yokochi, T. (2004) Piceatannol prevents lipopolysaccharide (LPS)-induced nitric oxide (NO) production and nuclear factor (NF)-kappaB activation by inhibiting IkappaB kinase (IKK). Microbiol. Immunol. 48: 729-736
18. James, S. L. (1995) Role of nitric oxide in parasitic infections. Microbiol. Rev. 59: 533-547
19. Johnson, G. L., Lapadat, R. (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912
20. Jones, S. A., Horiuchi, S., Topley, N., Yamamoto, N., Fuller, G. M. (2001) The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J. 15: 43-58
21. Kallen, K. J. (2002) The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochim. Biophys. Acta 1592: 323-343
22. Kapur, S., Picard, F., Perreault, M., Deshaies, Y., Marette, A. (2000) Nitric oxide: a new player in the modulation of energy metabolism. Int. J. Obes. Relat. Metab. Disord. 24: S36-S40
23. Karin, M. (1999a) The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J. Biol. Chem. 274: 27339-27342
24. Karin, M. (1999b) How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18: 6867-6874
25. Khan, I. A., Erdelmeier, C. A., Sticher, O., Rali, T. (1992) New phenolic glucosides from the leaves of Eurya tigang. J. Nat. Prod. 55: 1270-1274
26. Kim, J. K., Oh, S. M., Kwon, H. S., Oh, Y. S., Lim, S. S., Sin, H. K. (2006) Anti-inflammatory effect of roasted licorice extracts on lipopolysaccharide-induced inflammatory responses in murine macrophages. Biochem. Biophys. Res. Commun. 345: 1215-1223
27. Kolios, G., Valatas, V., Ward, S. G. (2004) Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 113: 427-437
28. Kwon, K. H., Barve, A., Yu, S., Huang, M. T., Kong, A. N. (2007) Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models. Acta. Pharmacol. Sin. 28: 1409-1421
29. Lee, S. B., Schorey, J. S. (2005) Activation and mitogen-activated protein kinase regulation of transcription factors Ets and NF-kappaB in Mycobacterium-infected macrophages and role of these factors in tumor necrosis factor alpha and nitric oxide synthase 2 promoter function. Infect. Immun. 73: 6499-6507
30. Lee, Y. W., Han, S. H., Lee, M., Yang, K. H., Kim, H. M., Jeon, Y. J. (2006) 2-Amino-3-methyhmidazo[4,5-f]quinoline inhibits nitric oxide production in lipopolysaccharide-stimulated RAW 264.7 cells by blocking p38 kinase activation. Cancer Lett. 156: 133-139
31. Libermann, T. A., Baltimore, D. (1990) Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell Biol. 10:2327-2334
32. Ma, W., Gee, K, Lim, W., Chambers, K., Angel, J. B., Kozlowski, M., Kumar, A. (2004) Dexamethasone inhibits IL-12p40 production in lipopolysaccharide-stimulated human monocytic cells by down-regulating the activity of c-Jun N-terminal kinase, the activation protein-1, and NF-kappa B transcription factors. J. Immunol. 172: 318-330
33. MacMicking, J., Xie, Q. W., Nathan, C. (1997) Nitric oxide and macrophage function. Annu. Rev. Immunol. 15: 323-350
34. Maruotti, N., Cantatore, F. P., Crivellato, E., Vacca, A., Ribatti, D. (2007) Macrophages in rheumatoid arthritis. Histol. Histopathol. 22: 581-586
35. Minagar, A., Shapshak, P., Fujimura, R., Ownby, R., Heyes, M., Eisdorfer, C. (2002) The role of macrophage/microglia and astro-cytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. Neurol. Sci. 202: 13-23
36. Murakami, A., Matsumoto, K., Koshimizu, K., Ohigashi, H. (2003) Effects of selected food factors with chemopreventive properties on combined lipopolysaccharide- and interferon-γ-induced IκB degradation in RAW264.7 macrophages. Cancer Lett. 195: 17-25
37. Murakami, A., Nishizawa, T., Egawa, K., Kawada, T., Nishikawa, Y., Uenakai, K., Ohigashi, H. (2005) New class of linoleic acid metabolites biosynthesized by com and rice lipoxygenases: suppression of proinflammatory mediator expression via attenuation of MAPK- and Akt-, but not PPARgamma-, dependent pathways in stimulated macrophages. Biochem. Pharmacol. 70: 1330-1342
38. Ohshima, H., Tazawa, H., Sylla, B. S., Sawa, T. (2005) Prevention of human cancer by modulation of chronic inflammatory processes. Mutat. Res. 591: 110-122
39. Pailsson-McDermott, E. M., O'Neill, L. A. (2004) Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113: 153-162
40. Park, S. Y., Yang, H. C., Moon, J. Y., Lee, N. H., Kim, S. J., Kang, J. H., Lee, Y. K., Park, D. B., Yoo, E. S., Kang, H. K. (2004) Induction of the apoptosis of HL-60 promyelocytic leukemia cells by Eurya emarginata. Cancer Lett. 205: 31-38
41. Park, S. Y., Yang, H. C., Moon, J. Y., Lee, N. H., Kim, S. J., Kang, J. H., Lee, Y. K., Park, D. B., Yoo, E. S., Kang, H. K. (2005a) The cytotoxicity of eutigosides from Eurya emarginata against HL-60 promyelocytic leukemia cells. Arch. Pharm. Res. 28: 1047-1052
42. Park, S. Y., Lee, H. J., Yoon, W. J., Kang, G. J., Moon, J. Y., Lee, N. H., Kim, S. J., Kang, H. K., Yoo, E. S. (2005b) Inhibitory effects of eutigosides isolated from Eurya emarginata on the inflammatory mediators in RAW264.7 cells. Arch. Pharm. Res. 28: 1244-1250
43. Patrignani, P., Tacconelli, S., Sciulli, M. G., Capone, M. L. (2005) New insights into COX-2 biology and inhibition. Brain Res. Rev. 48: 352-359
44. Rafi, M. M., Yadav, P. N., Rossi, A. O. (2007) Glucosamine inhibits LPS-induced COX-2 and iNOS expression in mouse macrophage cells (RAW 264.7) by inhibition of p38-MAP kinase and transcription factor NF-kappaB. Mol. Nutr. Food Res. 51: 587-593
45. Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., Davis, R. J. (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threo-nine. J. Biol. Chem. 270: 7420-7426
46. Stepien, K., Tomaszewski, M., Czuczwar, S. J. (2005) Neuroprotective properties of statins. Pharmacol. Rep. 57: 561-569
47. Suh, S. J., Chung, T. W., Son, M. J., Kim, S. H., Moon, T. C., Son, K. H., Kim, H. P., Chang, H. W., Kim, C. H. (2006) The naturally occurring biflavonoid, ochnaflavone, inhibits LPS-induced iNOS expression, which is mediated by ERK1/2 via NF-kappaB regulation, in RAW264.7 cells. Arch. Biochem. Biophys. 447: 136-146
48. Wadleigh, D. J., Reddy, S. T., Kopp, E., Ghosh, S., Herschman, H. R. (2000) Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW264.7 macrophages. J. Biol. Chem. 275: 6259-6266
49. Wang, T., Zhang, X., Li, J. J. (2002) The role of NF-kappaB in the regulation of cell stress responses. Int. Immunopharmacol. 2: 1509-1520
50. 2. Distinct roles of cyclooxygenase-1 and -2. J. Biol. Chem. 272: 25693-25699
51. Wung, B. S., Hsu, M. C., Wu, C. C., Hsieh, C. W. (2005) Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: effects on the inhibition of STAT3 phosphorylation. Life Sci. 78: 389-397